PRRT2 and ovarian carcinoma: Activation of various PKC isoforms through TPA has been shown to acutely and rapidly alter the phosphorylation state of TJ proteins and compromise barrier function of LLC-PK1 renal epithelium and ovarian cancer cell layers among others [62–64].